This result might provide evidence indicating a potential causality between Lp-PLA2 activity and hypertension and provides an impetus for reducing Lp-PLA2 activity or body weight to prevent progression to advanced hypertension, particularly in overweight subjects with the PLA2G7 279VV genotype. The gene discussed is PLA2G7; the disease is hypertensive disorder.